Dimensional Fund Advisors LP Annovis Bio, Inc. Transaction History

Dimensional Fund Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$5.55 - $19.62 $63,775 - $225,453	-11,491 Reduced 50.88%	11,095 $207,000
Q3 2023 Nov 09, 2023	SELL	$9.37 - $14.12 $24,971 - $37,629	-2,665 Reduced 10.55%	22,586 $214,000
Q1 2023 May 12, 2023	BUY	$12.33 - $22.1 $4,821 - $8,641	391 Added 1.57%	25,251 $389,000
Q4 2022 Feb 09, 2023	BUY	$10.99 - $13.8 $273,211 - $343,068	24,860 New	24,860 $333,000

1.17M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $44M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.